Nexstim New System Sales Update

- 27/09/2019

Helsinki, Finland: 27 September 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”)—the company developing and marketing a unique brain stimulation technology for diagnostics and therapy—announces it has sold one NBS System and two NBT® systems in August-September 2019.

The NBS system was purchased by a hospital in the United States and it will be used for pre-operative mapping in neurosurgery. The two NBT® systems are sold to hospitals in Italy and in Finland and they will be used mainly for therapy. All three systems have been sold as capital sales.

More info on Nexstim‘s website